Significance of initial ST segment changes for thrombolytic treatment in first inferior myocardial infarction

Heart

Volumn 77, Issue 6, 1997, Pages 506-511

  Schroder K ^a   Wegscheider, K ^a   Neuhaus, K L ^a   Tebbe, U ^a   Schroder R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Inferior myocardial infarction; Mortality; St segment deviation; Thrombolytic treatment

Indexed keywords

FIBRINOLYTIC AGENT; PLACEBO; RETEPLASE; STREPTOKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; TREATMENT OUTCOME;

EID: 0030788384     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.77.6.506     Document Type: Article

References (23)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311-22.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-60.
3. Kennedy JW, Atkins JM, Goldstein S, Jaffe AS, Lamberew CT, McIntyre KM, et al. Recent changes in management of acute myocardial infarction: implication for emergency care physicians. J Am Coll Cardiol 1988;11:446-9.
4. Braunwald E. Thrombolytic reperfusion of acute myocardial infarction: resolved and unresolved issues. J Am Coll Cardiol 1988;12:85-92A.
5. Bates ER, Clemmensen PM, Califf RM, Gorman LE, Aronson LG, George BS, et al. Precordial ST segment depression predicts a worse prognosis in inferior infarction despite reperfusion therapy. J Am Coll Cardiol 1990; 16:1538-44.
6. Murphy JF, Jain NL, Kahn MG, Romero CA. Inferior wall myocardial infarction and thrombolytic therapy: an appraisal of clinical heterogeneity and indications for treatment [abstract]. J Am Coll Cardiol 1995;25:207.
7. Bar FW, Vermeer F, De Zwaan C, Ramentol M, Braat S, Simoons ML, et al. Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1987;59:6-13.
8. Willems JL, Willems RJ, Willems GM, Arnold AER, Van de Werf F, Verstraete M. Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. Circulation 1990;82:1147-58.
9. ISAM (Intravenous Streptokinase in Acute Myocardial Infarction) Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity, and infarct size at 21 days. N Engl J Med 1986;314:1465-71.
10. Schröder R, Wegscheider K, Schröder K, Dissmann R, Meyer-Sabellek W, for the INJECT Trial Group. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimes. J Am Coll Cardiol 1995;26: 1657-64.
11. Glass GV. Note on rank-biserial correlation. Educational and Psychological Measurement 1966;26:623-31.
12. Tobé TJM. Is thrombolytic therapy in acute inferior myocardial infarction really better than conventional treatment? Br Heart J 1995;73:108-9.
13. Mauri F, Gasparini M, Barbonaglia L, Santoro E, Franzosi MG, Tognoni G, et al. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI Trial). Am J Cardiol 1989;63:1291-5.
14. Muller JE, Maroko PR, Braunwald E. Precordial electrocardiographic mapping: a technique to assess the efficacy of interventions designed to limit infarct size. Circulation 1978;57:1-18.
15. Aldrich HR, Wagner NB, Boswick J, Corsa AT, Jones MG, Grande P, et al. Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts. Am J Cardiol 1988;61:749-53.
16. Schröder R, Linderer T, Brüggemann T, Neuhaus K-L, Tebbe U, Wegscheider K, for the ISAM Study Group. Rationale for thrombolysis later than 4-6 h from symptom onset, and in patients with smaller myocardial infarction. Eur Heart J 1990;11(suppl F):19-28.
17. Mirvis DM. Physiologic bases for anterior ST segment depression in patients with acute inferior wall myocardial infarction. Am Heart J 1988;116:1308-22.
18. Hlatky MA, Califf RM, Lee KL, Pryor DB, Wagner GS, Rosati RA. Prognostic significance of precordial ST-segment depression during inferior acute myocardial infarction. Am J Cardiol 1985;55:325-9.
19. Wong CK, Freedman SB. Implications of ST changes in reperfusion management of acute myocardial infarction. Eur Heart J 1994;15:1385-90.
20. Lew AS, Maddahi J, Shah PK, Weiss AT, Peter T, Herman DS, et al. Factors that determine the direction and magnitude of precordial ST-segment deviations during inferior wall acute myocardial infarction. Am J Cardiol 1985;55:883-8.
21. Zehender M, Kasper W, Kauder E, Geibel A, Schönthaler M, Olschewski M, et al. Eligibility for and benefit of thrombolytic therapy in inferior myocardial infarction: focus on the prognostic importance of right ventricular infarction. J Am Coll Cardiol 1994;24:362-9.
22. Simoons ML, Maggioni AP, Knatterud G, Leimberger JD, de Jaegere P, van Domburg R, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 1993;342:1523-8.
23. Gore JM, Granger CB, Simoons ML, Sloan MA, Weaver WD, White HD, et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I Trial. Circulation 1995;92:281-8.